Live Breaking News & Updates on Analyst Recommendations For Ionis Pharmaceuticals

Stay updated with breaking news from Analyst recommendations for ionis pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives $56.08 Average Price Target from Analysts

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives $56.08 Average Price Target from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Joseph Baroldi , William Blair , News Ratings For Ionis Pharmaceuticals Daily , Insider Transactions At Ionis Pharmaceuticals , Hedge Funds Weigh In On Ionis Pharmaceuticals , Jpmorgan Chase Co , Ionis Pharmaceuticals Inc , Wolfe Research , Board Of Administration Florida Retirement System , Ionis Pharmaceuticals Price Performance , Analyst Recommendations For Ionis Pharmaceuticals , Bleakley Financial Group , Blair William Co , Securities Exchange Commission , Ionis Pharmaceuticals , Midwest Professional Planners , Get Free Report , Marketbeat Ratings , Director Joseph Klein , Exchange Commission , Professional Planners , Florida Retirement System , Financial Group , Get Free , Ionis Pharmaceuticals Daily ,

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Brokerages

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Brokerages
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Joseph Baroldi , Hedge Funds Weigh In On Ionis Pharmaceuticals , Securities Exchange Commission , Ionis Pharmaceuticals , Needham Company , Wells Fargo Company , Ionis Pharmaceuticals Inc , News Ratings For Ionis Pharmaceuticals Daily , Analyst Recommendations For Ionis Pharmaceuticals , Ionis Pharmaceuticals Stock Down , Mather Group , Royal Bank , Pingora Partners , Peoples Bank , Get Free Report , Wells Fargo , Director Joseph Klein , Exchange Commission , Valley Asset Management Partners , Pharmaceuticals Stock Down , Get Free , Ionis Pharmaceuticals Daily ,

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Cut to $82.00 by Analysts at Wells Fargo & Company

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Cut to $82.00 by Analysts at Wells Fargo & Company
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Joseph Baroldi , Piper Sandler , William Blair , Ionis Pharmaceuticals Company Profile , Fifth Third Bancorp , Grandfield Dodd , Ionis Pharmaceuticals Inc , Institutional Trading Of Ionis Pharmaceuticals , Ionis Pharmaceuticals , Wells Fargo Company , Royal Bank , Insider Transactions At Ionis Pharmaceuticals , Ionis Pharmaceuticals Trading Down , News Ratings For Ionis Pharmaceuticals Daily , Financial Services Group Inc , Victory Capital Management Inc , Analyst Recommendations For Ionis Pharmaceuticals , Securities Exchange Commission , Third Bancorp , Free Report , Wells Fargo , Moderate Buy , Pharmaceuticals Trading Down , Get Free Report , Director Joseph Klein ,

Wells Fargo & Company Trims Ionis Pharmaceuticals (NASDAQ:IONS) Target Price to $82.00

Wells Fargo & Company Trims Ionis Pharmaceuticals (NASDAQ:IONS) Target Price to $82.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Joseph Baroldi , Needham Company , Wells Fargo Company , Ionis Pharmaceuticals , Ionis Pharmaceuticals Inc , Grandfield Dodd , Ionis Pharmaceuticals Company Profile , Fifth Third Bancorp , Ionis Pharmaceuticals Price Performance , Third Bancorp , Securities Exchange Commission , Analyst Recommendations For Ionis Pharmaceuticals , Victory Capital Management Inc , Hedge Funds Weigh In On Ionis Pharmaceuticals , Financial Services Group Inc , Jpmorgan Chase Co , News Ratings For Ionis Pharmaceuticals Daily , Free Report , Wells Fargo , Moderate Buy , Get Free Report , Exchange Commission , Director Joseph Klein , Services Group ,

Ionis Pharmaceuticals (NASDAQ:IONS) Earns Buy Rating from Needham & Company LLC

Ionis Pharmaceuticals (NASDAQ:IONS) Earns Buy Rating from Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Joseph Baroldi , Piper Sandler , Lisanti Capital Growth , Charles Schwab Investment Management Inc , Ionis Pharmaceuticals Inc , Securities Exchange Commission , Analyst Recommendations For Ionis Pharmaceuticals , Jpmorgan Chase Co , Needham Company , Ionis Pharmaceuticals , Ionis Pharmaceuticals Company Profile , Wolfe Research , Ionis Pharmaceuticals Stock Performance , News Ratings For Ionis Pharmaceuticals Daily , Get Free Report , Exchange Commission , Director Joseph Klein , Minvest Partners , Schwab Investment Management , Capital Growth , Ionis Pharmaceuticals Daily ,